PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2010 2011
Building on the success of TBCAP and other programs, the USG is proposing a follow-on mechanism that will continue to support integration of TB-HIV/AIDS activities in three primary areas: a) enhancing the working relationships between NTLP and the AIDS Control Program (ACP); b) assisting the National Coordination Committee to develop National Program implementation plans; and c) providing supervisory and technical support at district and facility levels to improve TB/HIV collaborative activities. The proposed program will continue to leverage non-PEPFAR USAID funding for expansion of Community-Based (CB)-DOTS in PEPFAR-supported districts. These non-PEPFAR funds will provide district level support of CB-DOTS supervisors to oversee linkages between community and facility-based care, and between TB and HIV activities. In addition, the program will also increase focus on key technical priorities: improvement of Provider-Initiated HIV Counseling and Testing as well as linkage and referral of HIV-infected TB patients to HIV prevention, care and treatment; strengthening routine TB screening in PLHA; strengthening laboratory services to support TB diagnosis and treatment (including introduction of new technologies); TB Infection control; strengthening surveillance and management of multi-drug resistant TB; and strengthening program monitoring and evaluation.
This proposed program will continue to ensure that all activities maximize systems strengthening, capacity building and skills transfer so as to develop the sustained ability of the NTLP and health facilities to ensure access to quality TB and HIV services. It will also be expected to incorporate issues of gender and stigma/discrimination into all its activities for more appropriate/sensitive programming and also to link clients, were feasible, to health-related wrap-around services such as child survival activities, family planning, malaria treatment and safe motherhood programs.
The proposed new mechanism will be a USG flagship project for implementing TB control and TB/HIV activities in Uganda. It will be funded by USAID child survival infectious disease and GHCS funds. The program will focus on improving quality TB/HIV integrated activities as well as leverage and complement ongoing or planned non-PEPFAR USAID funding for TB and TB/HIV activities. In addition, the program will continue to provide support to National Tuberculosis and Leprosy Program (NTLP) and AIDS Control Program under the MOH, districts and USG implementing partners to roll out the TB/HIV integration policy guidelines and communication strategy. Based on assessment of population size, treatment success and case detection rates as well as presence of USG partner, the geographical coverage will cover, but not be limited to, 22 districts: Kampala, Wakiso, Mukono, Masaka, Kasese, Mubende, Nebbi, Masindi, Kibaale, Soroti, Arua, Mbarara, Mpigi, Kyenjojo, Hoima, Tororo, Luwero, Moyo, Yumbe, Adjumani, Mbale and Kayunga.
At the national level, the program will provide technical and financial support to the National Collaboration Committee on TB/HIV to roll out and monitor the TB/HIV national integration plan. The program will provide technical support to NTLP and ACP to set and monitor national targets for number and proportion of TB patients receiving HIV/AIDS Counseling and Testing (HCT) and, for those with TB/HIV co-infection, the number and proportion receiving co-trimoxazole prophylaxis and anti-retroviral therapy.
In the 22 districts, the program will provide technical support to the Directorate of District Health Services (DDHS) to form TB/HIV integration coordination committees, develop district plans and budgets and implement these plans. The districts will receive support to improve recording and reporting processes and provide regular/quarterly support supervision. At targeted health facilities, the program will provide financial and technical support to establish infection control committees within each facility to develop TB infection control action plans and implement infection control procedures. TB infection control activities will also be coordinated and integrated with other ongoing infection controls activities in the health facilities such as injection safety practices, blood safety etc. Provider-Initiated HIV Counseling and Testing (PICT) among TB patients will be scaled-up through training and provision of TB national guidelines to all health workers within TB clinics and wards. It is estimated that through support to these service outlets, 80% of registered TB patients will receive HIV/AIDS Counseling and Testing services and receive their test results and at least 80% of HIV-infected clients attending palliative care services will be screened and treated for TB. All the TB/HIV co-infected patients will receive co-trimoxazole prophylaxis and at least 40% of TB/HIV eligible clients will be initiated on ART.
The program will continue to support laboratory services to strengthen TB diagnostic capabilities through fortifying existing sputum smear microscopy networks as well as introduction of new technologies, where feasible. The program will ensure that external quality assurance is conducted in supported laboratories. Additional support will be provided to the national reference laboratories to provide quality assurance, mycobacterial culture and TB drug susceptibility testing including introduction of newer diagnostic methods for rapid detection of MDR TB. Laboratory workers and health staff will continue to be trained to carry out HIV/AIDS counseling and rapid HIV-testing.
In order to support the expansion of CB-DOTS, the program will provide technical support to the districts TB/HIV focal persons and continue to integrate CB-DOTS with HIV care and treatment programs. Follow-up and adherence support of TB/HIV co-infected patients will be strengthened using a combination of family support and community support mechanisms. The program will engage regional medical officers to mentor district TB and HIV focal persons, CB-DOTS supervisor and the Community Health and Outreach officers in initiating, implementing and monitoring TB/HIV integration activities.
The program will provide technical support and coordination to USG HIV/AIDS care and treatment partners to plan and implement complete TB package and TB/HIV collaborative activities.
